Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Starbucks (SBUX) PT Lowered to $108 at Barclays
-
Bernstein SocGen Group Downgrades Arm Holdings (ARM) to Underperform
-
Societe Generale: Third quarter 2024 earnings
-
Unitil Corp. (UTL) Appoints Jane Lewis-Raymond to its Board
-
Unitil Elects a New Member of the Board of Directors
-
Brinker Int'l (EAT) PT Raised to $95 at Barclays
-
EBay forecasts revenue below estimates on weak demand, shares fall
-
Judicate West Welcomes Polina Bernstein in Los Angeles
-
Bernstein SocGen Group Upgrades Burberry Group PLC (BRBY:LN) (BBRYF) to Outperform
-
Bernstein SocGen Group Reiterates Market Perform Rating on AMD (AMD)
-
Bernstein SocGen Group Downgrades Boeing (BA) to Market Perform
-
Chipotle Mexican Grill (CMG) PT Raised to $60 at Barclays
-
AMD shares slump as forecast disappoints AI-focused investors
-
Bernstein lists 8 large cap Japanese stocks for Growth and Quality investors
-
5 frequently asked questions and answers on Election prediction markets
-
Table22 Closes $11M Series A to Power Food and Beverage Merchants' E-Commerce Growth
-
FTV Capital Named to Inc.’s Founder-Friendly Investors List for Fourth Consecutive Year
-
Apple set for biggest revenue jump in two years on iPhone demand in China
-
Cruise operators reap benefits of their own private islands
-
Lufthansa reports 9% drop in third-quarter profit as core brand struggles
-
Top 10 questions Tesla investors are asking after earnings: Bernstein answers
-
The MoneyShow Alternative Investing Virtual Expo to Take Place Nov. 12-14, 2024
-
Tickets on Sale Now for the 24th Annual Food Network South Beach Wine & Food Festival Presented by Capital One
-
The Hartford Announces New Leadership Appointments In Global Specialty
-
Here's what to expect when Intel and AMD report earnings
-
Bernstein SocGen Group Upgrades Edwards Lifesciences (EW) to Market Perform
-
Acadia Realty Trust Reports Third Quarter Operating Results
-
Microsoft's AI demand under scrutiny as investors seek payday
-
Analysis-Musk's bold 2025 prediction on Tesla sales faces skepticism, scrutiny
-
Bernstein SocGen Group Reiterates Underperform Rating on Tesla (TSLA)
-
Bernstein SocGen Group Reiterates Outperform Rating on Coupang Inc (CPNG)
-
Bernstein SocGen Asks on Global Payments (GPN): 'Ready for a potential activist?'
-
Bernstein SocGen Group Starts StandardAero Inc (SARO) at Outperform
-
Is this stock ready for an activist investor? Bernstein weighs in
-
Indusind Bank Ltd (IIB:IN) PT Lowered to INR1,300 at Bernstein SocGen Group
-
Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
-
Maze Therapeutics Reports Positive First-in-Human Data From Phase 1 Healthy Volunteer Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease (AKD)
-
Celldex Announces Upcoming Late Breaking Oral Presentation of 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Inducible Urticaria at ACAAI 2024
-
Meta Platforms Inc. (META) PT Raised to $675 at Bernstein SocGen Group
-
Confluent Inc (CFLT) PT Lowered to $33 at Bernstein SocGen Group
-
Microsoft (MSFT) PT Lowered to $500 at Bernstein SocGen Group
-
DexCom (DXCM) PT Raised to $86 at Bernstein SocGen Group
-
eBay (EBAY) PT Raised to $70 at Bernstein SocGen Group
-
Bernstein SocGen Group Reiterates Outperform Rating on T-Mobile US, (TMUS )
-
General Motors (GM) PT Raised to $55 at Bernstein SocGen Group
-
Bernstein SocGen Group Reiterates Underperform Rating on Tesla (TSLA)
-
General Dynamics Corp. (GD) PT Lowered to $331 at Bernstein SocGen Group
-
Launch Loyalty Propels Dental Practices' Growth with Membership Plan Solutions
-
The Hartford Announces Excellent Third Quarter 2024 Financial Performance
-
ARS Pharmaceuticals Showcases Intranasal Epinephrine Data at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
